Tag Archives: Blood

September, 2017

14 September
Engineered Therapy for Blood Clotting Disorder Shows Early Promise

WASHINGTON, Sept. 14, 2017 /PRNewswire/ — An investigational treatment that mimics a key clotting enzyme is effective, safe, and may one day eliminate the need for blood products for people with the rare, life-threatening blood disease hereditary thrombotic thrombocytopenic purpura (TTP), according to a study published online today in Blood, …
Share

3 August
Kite Announces Publication of Landmark Study of Refractory Aggressive Non-Hodgkin Lymphoma Outcomes

SANTA MONICA, Calif.–(BUSINESS WIRE)–Kite Pharma, Inc., (Nasdaq:KITE), a leading cell therapy company, today highlighted the publication of the first large-scale multi-institutional analysis of outcomes of patients with refractory aggressive non-Hodgkin lymphoma (NHL) in the latest electronic edition of BLOOD. The study, SCHOLAR-1 (Retrospective Non-Hodgkin Lymphoma Research), showed outcomes in patients with refractory aggressive …
Share

16 December
Herpes Virus Linked to Most Common Type of Childhood Cancer

(WASHINGTON, December 15, 2016) — Newborns with congenital cytomegalovirus (CMV) — a common virus in the herpes family — may have an increased risk of developing acute lymphocytic leukemia (ALL), according to new research published online today in Blood, the Journal of the American Society of Hematology (ASH). The study suggests the …
Share

1 August
Over 750 Biomarkers Identified as Potentials for Early Cancer Screening Test

Researchers have identified 788 biomarkers in blood that could be used to develop an early stage cancer screening test for the general population. The study, led by the University of Sheffield, is the first to create a comprehensive list of relevant cancer blood biomarkers that have been researched in the …
Share

15 June
Autologous Stem Cell Transplantation Potentially Curative for HIV-Associated Lymphoma

(WASHINGTON –June 13, 2016) – New research published online today in Blood, the Journal of the American Society of Hematology (ASH), challenges the generally held belief that individuals with HIV and aggressive lymphoma are not candidates for standard treatment. According to researchers, people with HIV-associated lymphoma who receive autologous stem cell …
Share